FAU own research funding: EFI / IZKF / EAM ...
Start date : 16.04.2022
End date : 15.04.2023
Extension date: 15.10.2023
Vulvar cancer is a rare gynecologic tumor with increasing incidence. New therapeutic strategies include the use of checkpointinhibitors, but clinical data is limited and contradictory. In this project we aim to assess the expression of PD-L1 in vulvar cancer. The expression will be assessed independently in primary, recurrent and lymph node metastasis. The expression will be compared to the clinical status such as TNM, L-,V-,Pn-infiltration.